bezafibrate has been researched along with Acute Kidney Failure in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, R; Kaushal, GP; Nagothu, KK; Portilla, D | 1 |
| Heidland, A; Hörl, M; Hörl, WH | 1 |
| Bock, KD; Heidemann, H | 1 |
| Alcoy, E; García-Ramos, JL; Górriz, JL; Pallardó, LM; Sancho, A | 1 |
| Madden, BP; Millner, R; Parker, J; Rolfe, LM; Seymour, CA; Sharobeem, KM | 1 |
| Ben-Chetrit, S; Bernheim, J; Korzets, Z; Mor, A; Plotkin, E | 1 |
| Kamaliah, MD; Sanjay, LD | 1 |
| Cordi, GC; Corsi, L; Dapelo, M; De Micheli, A; Grimaldi, GP; Venzano, C | 1 |
| Benker, G; Cissewski, K; Kienast, K; Reinwein, D; Windeck, R | 1 |
9 other study(ies) available for bezafibrate and Acute Kidney Failure
| Article | Year |
|---|---|
Fibrate prevents cisplatin-induced proximal tubule cell death.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bezafibrate; Caspase 3; Caspases; Cisplatin; Cytochromes c; Drug Interactions; Fatty Acids, Nonesterified; Hypolipidemic Agents; Kidney Tubules, Proximal; Ligands; LLC-PK1 Cells; Mitochondria; Oxidation-Reduction; PPAR alpha; Swine | 2005 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Infusions, Parenteral; Kidney Failure, Chronic; Lipids; Physical Exertion; Rats; Renal Dialysis | 1982 |
[Rhabdomyolysis with acute renal failure due to bezafibrate].
Topics: Acute Kidney Injury; Bezafibrate; Clofibrate; Clofibric Acid; Humans; Male; Middle Aged; Muscular Diseases | 1981 |
Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Humans; Hypolipidemic Agents; Male; Rhabdomyolysis | 1995 |
Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group.
Topics: Acute Kidney Injury; Aged; Anticholesteremic Agents; Bezafibrate; Cardiopulmonary Bypass; Clofibric Acid; Female; Fibric Acids; Humans; Male; Middle Aged; Rhabdomyolysis | 2000 |
Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Influenza Vaccines; Male; Pyridines; Rhabdomyolysis | 2000 |
Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Topics: Acute Kidney Injury; Aged; Bezafibrate; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Diseases; Male; Rhabdomyolysis | 2001 |
[A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
Topics: Acute Disease; Acute Kidney Injury; Aged; Bezafibrate; Female; Furosemide; Humans; Rhabdomyolysis | 1990 |
[Bezafibrate-induced myoglobinuric kidney failure in a 54-year-old patient with diabetes mellitus type IIa].
Topics: Acute Kidney Injury; Bezafibrate; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Middle Aged; Myoglobinuria; Rhabdomyolysis | 1988 |